Skip to main content

Humedix Co., Ltd. (200670.KQ)

KOE Healthcare Drug Manufacturers - Specialty & GenericView data quality →
67.5Fair

ValueMarkers Composite Index

Top 97%#1,258 of 44,722
Undervalued

52% below intrinsic value ($48)

UndervaluedFair ValueOvervalued
Piotroski
4/9
Neutral
Beneish
-0.51
High Risk
Altman
11.01
Safe
DCF Value
$48
Undervalued
ROIC
11.3%
Adequate
P/E
20.3
Fair
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Humedix Co., Ltd. (200670.KQ) — VMCI valuation read

Across 120 indicators, Humedix Co., Ltd. (200670.KQ) lands at VMCI 68/100. The Healthcare sector median is 50, so the 18-point above-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on 200670.KQ in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, 200670.KQ trades at 25.0x earnings, 39% above the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 13.0% sits 3.0pp above the Healthcare median (10.0%). On Risk, net debt to EBITDA of -1.7x leaves covenant headroom for 200670.KQ on the trailing balance sheet.

200670.KQ rose 2.2% over the trailing 7 days, with a +4.3% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.